中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
Chinese Journal of Oncology
2015年
11期
859-862
,共4页
闫岩%徐晨琛%王涛%刘洁%刘跃华
閆巖%徐晨琛%王濤%劉潔%劉躍華
염암%서신침%왕도%류길%류약화
淋巴瘤,T细胞,皮肤%真菌病,蕈样%PUVA疗法%紫外线疗法%治疗结果
淋巴瘤,T細胞,皮膚%真菌病,蕈樣%PUVA療法%紫外線療法%治療結果
림파류,T세포,피부%진균병,심양%PUVA요법%자외선요법%치료결과
Lymphoma,T-cell,cutaneous%Mycosis fungoides%PUVA therapy%Ultraviolet therapy%Treatment outcome
目的 探讨局部甲氧沙林加紫外线A (PUVA)治疗难治性蕈样肉芽肿(MF)皮损的有效性和安全性.方法 回顾分析2008年至2014年就诊、治疗并长期随访的150例MF患者的资料,其中有10例符合入选标准及排除标准,其中男4例,女6例,年龄(46.0±9.4)岁,病程(12.4±7.7)年.其中斑块期7例,肿瘤期3例,皮损数量为(1.9±0.9)个.治疗区域外用补骨脂酊30 min后行全身紫外线A(UVA)照射治疗,每周3次,评估治疗有效率以及不良反应发生率.结果 10例MF患者局部PUVA的治疗次数为(18.10±14.61)次,总剂量为(161.60±135.96) J/cm2.患者接受UVA照射的总剂量为(1 953.25±829.73) J/cm2,治疗次数为(261.90± 116.79)次,治疗时间为(45.80±26.64)个月.全组患者完全缓解6例,部分缓解3例,无效1例,有效率为90.0%.全组患者未见明显严重的不良反应.结论 局部PUVA治疗难治性MF皮损有效率高,并具有较好的安全性.
目的 探討跼部甲氧沙林加紫外線A (PUVA)治療難治性蕈樣肉芽腫(MF)皮損的有效性和安全性.方法 迴顧分析2008年至2014年就診、治療併長期隨訪的150例MF患者的資料,其中有10例符閤入選標準及排除標準,其中男4例,女6例,年齡(46.0±9.4)歲,病程(12.4±7.7)年.其中斑塊期7例,腫瘤期3例,皮損數量為(1.9±0.9)箇.治療區域外用補骨脂酊30 min後行全身紫外線A(UVA)照射治療,每週3次,評估治療有效率以及不良反應髮生率.結果 10例MF患者跼部PUVA的治療次數為(18.10±14.61)次,總劑量為(161.60±135.96) J/cm2.患者接受UVA照射的總劑量為(1 953.25±829.73) J/cm2,治療次數為(261.90± 116.79)次,治療時間為(45.80±26.64)箇月.全組患者完全緩解6例,部分緩解3例,無效1例,有效率為90.0%.全組患者未見明顯嚴重的不良反應.結論 跼部PUVA治療難治性MF皮損有效率高,併具有較好的安全性.
목적 탐토국부갑양사림가자외선A (PUVA)치료난치성심양육아종(MF)피손적유효성화안전성.방법 회고분석2008년지2014년취진、치료병장기수방적150례MF환자적자료,기중유10례부합입선표준급배제표준,기중남4례,녀6례,년령(46.0±9.4)세,병정(12.4±7.7)년.기중반괴기7례,종류기3례,피손수량위(1.9±0.9)개.치료구역외용보골지정30 min후행전신자외선A(UVA)조사치료,매주3차,평고치료유효솔이급불량반응발생솔.결과 10례MF환자국부PUVA적치료차수위(18.10±14.61)차,총제량위(161.60±135.96) J/cm2.환자접수UVA조사적총제량위(1 953.25±829.73) J/cm2,치료차수위(261.90± 116.79)차,치료시간위(45.80±26.64)개월.전조환자완전완해6례,부분완해3례,무효1례,유효솔위90.0%.전조환자미견명현엄중적불량반응.결론 국부PUVA치료난치성MF피손유효솔고,병구유교호적안전성.
Objective To evaluate the efficacy and safety of topical PUVA treatment of refractory lesions of mycosis fungoides.Methods From January 2008 to 2014, a total of 10 patients(4 males and 6 females) with mycosis fungoides were treated with topical PUVA in Peking Union Medical College Hospital, including 7 cases in plaque stage and 3 cases in tumor stage.The average number of lesions were 1.9±0.9.The median age of these patients was (46.0±9.4) years.The average course of disease was (12.4±7.7) years.Psoralen was applied topically on treatment area 30 min before total body UVA irradiation treatment, 3 times a week.And the efficiency and safety of the therapy were evaluated.Results All the patients were treated with topical PUVA with a median total dose of (161.60±135.96) J/cm2 in an average of (18.10±14.61) fractions.Total dose of UVA was (1 953.25±829.73) J/cm2, and total number of treatment was (261.90± 116.79) fractions.The total treatment time was (45.80±26.64) months.Complete clinical response (CR) rate was 60.0%, partial response (PR) rate was 30.0%, and the overall response rate (CR+PR) was 90.0%.One patient showed no response.No severe acute or chronic side effects were observed.Conclusion Topical PUVA therapy is effective in the treatment of refractory lesions of mycosis fungoides with little severe side effects.